XML 79 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Narrative) (Details) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended 6 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Controlling Interest [Member]
center
Sep. 30, 2013
Controlling Interest [Member]
center
Dec. 31, 2011
National Surgical Care, Inc. [Member]
center
Sep. 30, 2013
National Surgical Care, Inc. [Member]
Jul. 16, 2014
Sheridan Healthcare [Member]
Sep. 30, 2014
Sheridan Healthcare [Member]
Jul. 16, 2014
Sheridan Healthcare [Member]
Jul. 16, 2014
Common Stock [Member]
Jul. 02, 2014
Common Stock [Member]
Jul. 16, 2014
Common Stock [Member]
Sheridan Healthcare [Member]
Jul. 16, 2014
Mandatory Convertible Preferred Stock [Member]
Jul. 02, 2014
Mandatory Convertible Preferred Stock [Member]
Jul. 16, 2014
Senior Secured Credit Facility - Term Loan [Member]
Jul. 15, 2014
Revolving Credit Facility [Member]
Jul. 16, 2014
Revolving Credit Facility [Member]
Jul. 16, 2014
Senior Notes [Member]
2022 Senior Unsecured Notes [Member]
Sep. 30, 2014
Bridge Loan [Member]
Interest Expense [Member]
Sheridan Healthcare [Member]
Sep. 30, 2014
Ambulatory Services [Member]
Sep. 30, 2013
Ambulatory Services [Member]
Business Acquisition [Line Items]                                              
Cash paid to acquire business                 $ 2,100,000,000                            
Shares of common stock issued for acquisition                           5,713,909                  
Value of common stock issued for acquisition                     272,000,000                        
Issuance of common stock (in shares)                         9,775,000     1,725,000              
Proceeds from common stock offering     439,875,000 0               421,000,000                      
Proceeds from preferred stock offering     172,500,000 0                     166,400,000                
Maximum borrowing capacity                                 870,000,000.0 475,000,000.0 300,000,000.0        
Face amount                                       1,100,000,000.0      
Interest rate                                       5.625%      
Fees and expenses associated with acquisition                   135,700,000                          
Deferred financing costs                   52,900,000                          
Payments of equity issuance costs     (24,366,000) 0                                      
Transaction costs 25,102,000 110,000 28,681,000 285,000                                      
Fees paid to obtain a commitment for financing                                         12,800,000    
Debt extinguishment costs (16,887,000) 0 (16,887,000) 0                           (4,500,000)          
Number of business acquisitions         2 4 17                                
Acquisitions and related expenses, net     2,138,648,000 59,455,000                                   24,400,000 59,500,000
Final settlement of contingent earn out fee               $ 2,700,000